297 related articles for article (PubMed ID: 15938721)
21. [Proteomics techniques and their application in haemato-oncologic malignancies].
Zelená J; Hájek R
Cas Lek Cesk; 2007; 146(7):586-92. PubMed ID: 17722845
[TBL] [Abstract][Full Text] [Related]
22. [Optimising therapy in patients with haematological malignancies].
Dumontet C
Bull Cancer; 2008 Oct; 95(10):959-62. PubMed ID: 19004726
[TBL] [Abstract][Full Text] [Related]
23. Systemic mastocytosis with associated myeloproliferative disease and precursor B lymphoblastic leukaemia with t(13;13)(q12;q22) involving FLT3.
Tzankov A; Sotlar K; Muhlematter D; Theocharides A; Went P; Jotterand M; Horny HP; Dirnhofer S
J Clin Pathol; 2008 Aug; 61(8):958-61. PubMed ID: 18663058
[TBL] [Abstract][Full Text] [Related]
24. Molecular hematology. Qualitative to quantitative techniques.
Khalil SH
Saudi Med J; 2005 Oct; 26(10):1516-22. PubMed ID: 16228048
[TBL] [Abstract][Full Text] [Related]
25. Genetics of myeloid malignancies: pathogenetic and clinical implications.
Fröhling S; Scholl C; Gilliland DG; Levine RL
J Clin Oncol; 2005 Sep; 23(26):6285-95. PubMed ID: 16155011
[TBL] [Abstract][Full Text] [Related]
26. Pattern of trisomy 1q in hematological malignancies: a single institution experience.
Djordjević V; Dencić-Fekete M; Jovanović J; Drakulić D; Stevanović M; Janković G; Gotić M
Cancer Genet Cytogenet; 2008 Oct; 186(1):12-8. PubMed ID: 18786437
[TBL] [Abstract][Full Text] [Related]
27. Cytogenetic and molecular analysis of MLL rearrangements in acute lymphoblastic leukaemia survivors.
Brassesco MS; Montaldi AP; Gras DE; Camparoto ML; Martinez-Rossi NM; Scrideli CA; Tone LG; Sakamoto-Hojo ET
Mutagenesis; 2009 Mar; 24(2):153-60. PubMed ID: 19028982
[TBL] [Abstract][Full Text] [Related]
28. Molecular diagnosis of childhood acute leukemia: Serbian experience.
Krstic AD; Micic D; Lakic N; Guc-Scekic M; Janic D
Pediatr Blood Cancer; 2010 Aug; 55(2):394-5. PubMed ID: 20582960
[No Abstract] [Full Text] [Related]
29. Molecular diagnostic cytopathology: definitions, scope and clinical utility.
Salto-Tellez M; Koay ES
Cytopathology; 2004 Oct; 15(5):252-5. PubMed ID: 15456412
[TBL] [Abstract][Full Text] [Related]
30. [Review of relationship between tumor necrosis factor genetic polymorphism and hematological malignancies].
Zhao HY; Chen YX
Ai Zheng; 2003 Feb; 22(2):216-20. PubMed ID: 12600304
[TBL] [Abstract][Full Text] [Related]
31. Tumor M2-PK levels in haematological malignancies.
Oremek GM; Rox S; Mitrou P; Sapoutzis N; Sauer-Eppel H
Anticancer Res; 2003; 23(2A):1135-8. PubMed ID: 12820361
[TBL] [Abstract][Full Text] [Related]
32. [Molecular diagnosis of lymphomas and leukaemias].
Jurkowska M; Zekanowski C; Malinowska I; Zielenska M
Med Wieku Rozwoj; 2001; 5(2):113-34. PubMed ID: 11679676
[TBL] [Abstract][Full Text] [Related]
33. Modern diagnostics in acute leukemias.
Haferlach T; Kern W; Schnittger S; Schoch C
Crit Rev Oncol Hematol; 2005 Nov; 56(2):223-34. PubMed ID: 16213152
[TBL] [Abstract][Full Text] [Related]
34. The diagnostic interface between histology and molecular tests in myeloproliferative disorders.
Tefferi A; Vardiman JW
Curr Opin Hematol; 2007 Mar; 14(2):115-22. PubMed ID: 17255788
[TBL] [Abstract][Full Text] [Related]
35. [Molecular biology in acute lymphoblastic leukemia].
Hokland P; Pallisgaard N
Ugeskr Laeger; 2001 Aug; 163(35):4721-4. PubMed ID: 11572044
[No Abstract] [Full Text] [Related]
36. Detection and monitoring of minimal residual disease by quantitative real-time PCR.
Schüler F; Dölken G
Clin Chim Acta; 2006 Jan; 363(1-2):147-56. PubMed ID: 16154122
[TBL] [Abstract][Full Text] [Related]
37. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
38. Cluster analysis of genomic ETV6-RUNX1 (TEL-AML1) fusion sites in childhood acute lymphoblastic leukemia.
von Goessel H; Jacobs U; Semper S; Krumbholz M; Langer T; Keller T; Schrauder A; van der Velden VH; van Dongen JJ; Harbott J; Panzer-Grümayer ER; Schrappe M; Rascher W; Metzler M
Leuk Res; 2009 Aug; 33(8):1082-8. PubMed ID: 19081626
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic refinement of chronic myeloproliferative disorders and thrombocytoses of unknown origin by multiple RT-PCR and capillary electrophoresis of BCR-ABL rearrangements and JAK2 (V617F) mutation.
Ammatuna E; Ottone T; Zaza S; Lavorgna S; Grillo R; Curzi P; Panetta P; Federici G; Amadori S; Lo-Coco F
Ann Hematol; 2007 May; 86(5):355-61. PubMed ID: 17285276
[TBL] [Abstract][Full Text] [Related]
40. Interphase cytogenetics of hematological neoplasms under the perspective of the novel WHO classification.
Martín-Subero JI; Gesk S; Harder L; Grote W; Siebert R
Anticancer Res; 2003; 23(2A):1139-48. PubMed ID: 12820362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]